Literature DB >> 11845575

[The Medical School of Split--overview of its activity from independence until today].

D Sapunar1.   

Abstract

The aim of this report is to describe the current status of medical education program in the University of Split Medical School and to investigate readiness to accept modern trends in medical education. The report comprises the four-year period, since establishment of independent medical school up to day. The crucial elements of the high education reform with special emphasis on medical education are included in the report. The development of the faculty is still burdened with lack of personnel, poor market orientation and relatively small scientific production. The financial report, scientific production data, and information about student performance are also included. The decision that all exams must be passed before enrolment to the next academic year showed full justification. Although exposed to strong criticism, our new curriculum implemented four year ago is still unchanged. Joint effort of all medical schools in Croatia has to be directed to the follow up of all information important for the medical education, development of the quality assurance mechanisms and to enhancing state examination, standard for the evaluation of the medical schools' quality.

Mesh:

Year:  2001        PMID: 11845575

Source DB:  PubMed          Journal:  Lijec Vjesn        ISSN: 0024-3477


  2 in total

1.  Predictors of attrition and academic success of medical students: a 30-year retrospective study.

Authors:  Silvija Maslov Kruzicevic; Katarina Josipa Barisic; Adriana Banozic; Carlos David Esteban; Damir Sapunar; Livia Puljak
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

2.  Impact of extended course duration and stricter study organization on attrition and academic performance of medical students.

Authors:  Roberta Andrea Tešija; Silvija Maslov Kružičević; Adriana Banožić; Carlos David Esteban; Damir Sapunar; Livia Puljak
Journal:  Croat Med J       Date:  2013-04       Impact factor: 1.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.